Read the press release here.
January 12, 2017 By
FDA removes the contraindication for use of Bracco Diagnostics Inc.’s LUMASON® in patients with cardiac shunts
Read the press release here.
Copyright © 2023 ·Executive Theme · Genesis Framework by StudioPress · WordPress · Log in
Copyright © 2023 American Society of Echocardiography